DBV Technologies S.A. (NASDAQ:DBVT – Get Rating) – Stock analysts at HC Wainwright lowered their Q2 2023 earnings estimates for DBV Technologies in a research report issued on Tuesday, May 9th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings per share of ($0.13) for the quarter, down from their previous […]
StockNews.com initiated coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report released on Monday morning. The firm issued a sell rating on the stock. DBVT has been the topic of a number of other research reports. Societe Generale raised shares of DBV Technologies from a hold rating to a buy rating […]
StockNews.com initiated coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report released on Monday morning. The brokerage issued a sell rating on the stock. A number of other equities research analysts have also commented on DBVT. HC Wainwright restated a buy rating and set a $10.00 price objective on shares of […]
DBV Technologies (NASDAQ:DBVT – Get Rating) and Solid Biosciences (NASDAQ:SLDB – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability. Profitability This table compares DBV Technologies and Solid Biosciences’ […]